🇺🇸 Advanced Eye Relief in United States
113 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 113
Most-reported reactions
- Eye Irritation — 30 reports (26.55%)
- Eye Pain — 17 reports (15.04%)
- Ocular Hyperaemia — 14 reports (12.39%)
- Drug Ineffective — 10 reports (8.85%)
- Vision Blurred — 9 reports (7.96%)
- Eye Pruritus — 8 reports (7.08%)
- Condition Aggravated — 7 reports (6.19%)
- Erythema — 7 reports (6.19%)
- Lacrimation Increased — 6 reports (5.31%)
- Expired Product Administered — 5 reports (4.42%)
Other Ophthalmology approved in United States
Frequently asked questions
Is Advanced Eye Relief approved in United States?
Advanced Eye Relief does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Advanced Eye Relief in United States?
Galderma R&D is the originator. The local marketing authorisation holder may differ — check the official source linked above.